Reductil 15MG


Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 40.7%
Obesity 13.9%
Weight Control 11.6%
Drug Exposure During Pregnancy 3.9%
Hypertension 3.9%
Overweight 3.6%
Product Used For Unknown Indication 3.3%
Weight Decreased 3.0%
Contraception 2.8%
Diabetes Mellitus 2.5%
Pain 2.5%
Asthma 1.7%
Atrial Fibrillation 1.1%
Headache 1.1%
Hypotonia 1.1%
Abdominal Discomfort 0.8%
Type 2 Diabetes Mellitus 0.8%
Gestational Diabetes 0.6%
Hypersensitivity 0.6%
Hypothyroidism 0.6%
Abortion Induced 23.5%
Syncope 7.1%
Ventricular Tachycardia 7.1%
Sudden Death 5.9%
Abortion Spontaneous 4.7%
Mood Swings 4.7%
Tachycardia 4.7%
Thrombosis 4.7%
Drug Exposure During Pregnancy 3.5%
Dyspnoea 3.5%
Maternal Drugs Affecting Foetus 3.5%
Neoplasm 3.5%
Pregnancy 3.5%
Speech Disorder 3.5%
Trigeminal Neuralgia 3.5%
Vision Blurred 3.5%
Acute Myocardial Infarction 2.4%
Cardiac Failure Chronic 2.4%
Cerebral Infarction 2.4%
Diabetes Mellitus 2.4%
Secondary
Drug Use For Unknown Indication 31.4%
Obesity 16.7%
Product Used For Unknown Indication 15.7%
Weight Increased 7.8%
Weight Control 6.9%
Overweight 4.9%
Contraception 3.9%
Hypertension 3.9%
Diabetes Mellitus 2.9%
Drug Exposure During Pregnancy 2.0%
Hypersensitivity 2.0%
Oedema Peripheral 1.0%
Prophylaxis 1.0%
Thrombocytopenic Purpura 15.4%
Vaginal Haemorrhage 15.4%
Syncope 9.6%
Mood Swings 7.7%
Thrombosis 7.7%
Pyrexia 5.8%
Abortion Induced 3.8%
Acute Myocardial Infarction 3.8%
Haemorrhoidal Haemorrhage 3.8%
Hearing Impaired 3.8%
Tri-iodothyronine Free Increased 3.8%
Ventricular Tachycardia 3.8%
Abortion 1.9%
Cardiovascular Disorder 1.9%
Haemorrhage Subcutaneous 1.9%
Hypercholesterolaemia 1.9%
Left Ventricular Failure 1.9%
Pregnancy 1.9%
Pulmonary Embolism 1.9%
Rash 1.9%

Drug Data